These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 20331763

  • 1. The analysis of JAK2 and MPL mutations and JAK2 single nucleotide polymorphisms in MPN patients by MassARRAY assay.
    Zhang SJ, Qiu HX, Li JY, Shi JY, Xu W.
    Int J Lab Hematol; 2010 Aug 01; 32(4):381-6. PubMed ID: 20331763
    [Abstract] [Full Text] [Related]

  • 2. MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders.
    Ma W, Zhang X, Wang X, Zhang Z, Yeh CH, Uyeji J, Albitar M.
    Diagn Mol Pathol; 2011 Mar 01; 20(1):34-9. PubMed ID: 21326037
    [Abstract] [Full Text] [Related]

  • 3. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
    Hussein K, Bock O, Theophile K, von Neuhoff N, Buhr T, Schlué J, Büsche G, Kreipe H.
    Exp Hematol; 2009 Oct 01; 37(10):1186-1193.e7. PubMed ID: 19616600
    [Abstract] [Full Text] [Related]

  • 4. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ, Berneman Z, Schroyens W, De Raeve H.
    Acta Haematol; 2015 Oct 01; 133(1):36-51. PubMed ID: 25116092
    [Abstract] [Full Text] [Related]

  • 5. Detection of MPL exon10 mutations in 103 Chinese patients with JAK2V617F-negative myeloproliferative neoplasms.
    Chen X, Qi X, Tan Y, Xu Z, Xu A, Zhang L, Wang H.
    Blood Cells Mol Dis; 2011 Jun 15; 47(1):67-71. PubMed ID: 21555228
    [Abstract] [Full Text] [Related]

  • 6. JAK2 and MPL gene mutations in V617F-negative myeloproliferative neoplasms.
    Siemiatkowska A, Bieniaszewska M, Hellmann A, Limon J.
    Leuk Res; 2010 Mar 15; 34(3):387-9. PubMed ID: 19643476
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms.
    Lin Y, Liu E, Sun Q, Ma J, Li Q, Cao Z, Wang J, Jia Y, Zhang H, Song Z, Ai X, Shi L, Feng X, Li C, Wang J, Ru K.
    Am J Clin Pathol; 2015 Jul 15; 144(1):165-71. PubMed ID: 26071474
    [Abstract] [Full Text] [Related]

  • 9. The mutation profile of JAK2, MPL and CALR in Mexican patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
    Labastida-Mercado N, Galindo-Becerra S, Garcés-Eisele J, Colunga-Pedraza P, Guzman-Olvera V, Reyes-Nuñez V, Ruiz-Delgado GJ, Ruiz-Argüelles GJ.
    Hematol Oncol Stem Cell Ther; 2015 Mar 15; 8(1):16-21. PubMed ID: 25637689
    [Abstract] [Full Text] [Related]

  • 10. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
    Teofili L, Giona F, Martini M, Cenci T, Guidi F, Torti L, Palumbo G, Amendola A, Foà R, Larocca LM.
    J Clin Oncol; 2007 Mar 20; 25(9):1048-53. PubMed ID: 17369568
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of CALR, JAK2 and MPL gene mutations in BCR-ABL negative myeloproliferative neoplasms].
    Ouyang Y, Qiao C, Wang J, Xiao L, Zhang S.
    Zhonghua Yi Xue Za Zhi; 2015 May 12; 95(18):1369-73. PubMed ID: 26178351
    [Abstract] [Full Text] [Related]

  • 12. TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
    Trifa AP, Bănescu C, Tevet M, Bojan A, Dima D, Urian L, Török-Vistai T, Popov VM, Zdrenghea M, Petrov L, Vasilache A, Murat M, Georgescu D, Popescu M, Pătrinoiu O, Balea M, Costache R, Coleș E, Șaguna C, Berbec N, Vlădăreanu AM, Mihăilă RG, Bumbea H, Cucuianu A, Popp RA.
    Br J Haematol; 2016 Jul 12; 174(2):218-26. PubMed ID: 27061303
    [Abstract] [Full Text] [Related]

  • 13. Study of CALR, MPL, and c-kit Gene Mutations in Thai Patients with JAK2 V617F Negative Myeloproliferative Neoplasms.
    Wiriyaukaradecha K, Nimsanor S, Tantirukdham N, Tongsom J, Bunyoo C, Soonklang K, Sritana N, Auewarakul C.
    Asian Pac J Cancer Prev; 2022 May 01; 23(5):1671-1678. PubMed ID: 35633552
    [Abstract] [Full Text] [Related]

  • 14. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.
    Kilpivaara O, Levine RL.
    Leukemia; 2008 Oct 01; 22(10):1813-7. PubMed ID: 18754026
    [Abstract] [Full Text] [Related]

  • 15. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Michiels JJ, De Raeve H, Berneman Z, Van Bockstaele D, Hebeda K, Lam K, Schroyens W.
    Semin Thromb Hemost; 2006 Jun 01; 32(4 Pt 2):307-40. PubMed ID: 16810609
    [Abstract] [Full Text] [Related]

  • 16. Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India.
    Rabade N, Subramanian PG, Kodgule R, Raval G, Joshi S, Chaudhary S, Mascarenhas R, Tembhare P, Gujral S, Patkar N.
    Indian J Pathol Microbiol; 2018 Jun 01; 61(2):209-213. PubMed ID: 29676359
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rapid real-time PCR assay for detection of MPL W515L mutation in patients with chronic myeloproliferative disorders.
    Ghaderi M, Strömberg O, Porwit A.
    Int J Lab Hematol; 2010 Feb 01; 32(1 Pt 2):122-6. PubMed ID: 19016916
    [Abstract] [Full Text] [Related]

  • 19. Mutations in the JAK2 and MPL genes and their correlation to clinical parameters in patients with chronic myeloproliferative disease.
    Bojko P, Abenhardt W, Schnittger S, Haferlach T.
    Onkologie; 2009 Apr 01; 32(4):191-5. PubMed ID: 19372714
    [Abstract] [Full Text] [Related]

  • 20. Molecular characterization of chronic myeloproliferative neoplasias in México.
    Ruiz-Argüelles GJ, Garcés-Eisele J, Ortiz-López R, Rivas-Llamas R, Gómez-Almaguer D, Ruiz-Delgado GJ.
    Hematology; 2009 Oct 01; 14(5):261-5. PubMed ID: 19843380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.